cancer





About Mediscience Detection
History
Strategy
Business
Technical
product
clinical
Cancer

MEDISCIENCE TECHNOLOGY Home Page

Mediscience Technology Corp. is engaged in the design and development of diagnostic medical devices that detect cancer using light induced native tissue fluorescence spectroscopy to distinguish between malignant and normal or benign tissue.

8-K filing accepted for Feb 18, 2004 Click here.

8-K filing accepted for Feb 2, 2004 Click here.

8-K filing accepted for Dec 3, 2003 Click here.

Nov. 24, 2003 - Breakthrough in Detecting Cancerous Tissue via Stokes Shift Emission Spectroscopy Click here.

July 16, 2003 - CCNY Receives $6 Million NASA Grant To Enhance Photonics Research Click here.

10-Q SB filed May 31, 2003 Click here.

January 22, 2003-Strategy and Biography of the THM Group, L.L.C. Click here.

The following presentation entitled "Optical Biomedical Imaging" describes another light based diagnostic technology developed by Mediscience Technology Corp. This technology is in addition to the fluorescence spectroscopy also developed by Mediscience. Click here.

Web Broadcast by Prof. Robert R. Alfano about fluorescence spectroscopy Click here to watch.



Company Highlights

May 2, 2004: News Release:
Mediscience Technology Corp. Announces Project Agreement For Development Of Cancer Detection And Diagnosis Device With Research Foundation Of The City University Of New York
click here

April 14, 2004: News Release:
Mediscience Technology Corp. Names Robert G. Pinco to Advisory Council
click here

February  2, 2004: News Release:
Mediscience Technology Corp. (otc-mdsc) announces the successful closing of a $1.5 Million dollars Private Placement as of February 1, 2004
click here

December 17, 2003: News Release:
the FDA qualified the Mediscience Technology Corp. for both reduced or waived FDA fees for its 2004 medical device 510K market approval submissions
click here

December 3, 2003: News Release:
Mediscience Technology Corp. OTC-MDSC Secures Exclusive World-Wide License to US Molecular Imaging Patent Applications, Expected to Extend Core Technology Additional 17+ Years
click here

June 4, 2003: News Release:
Mediscience Technology Announces Formation Of New Subsidiary To Develop Potential Clinical Application For Non-Invasively Diagnosis Of Prostate Cancers
click here

April 28, 2003: News Release:
Mediscience Technology Appoints Michael Engelhart President and Chief Operating Officer effective immediately.
click here

January 22, 2003: News Release:
Mediscience Technology Selects THM Group For Commercialization Phase Of Cancer Detection Technology
click here